CRIS Curis Inc BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Curis (CRIS) Stock: Buy, Sell, or Hold?

$0.45
-0.13 (-22.18%) β–Ό
5d: -50.91% 30d: -12.4% 90d: -75.28%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (47%)
Quality Score
41/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.42 – $0.78
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$42.67
+9488.0% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.43 / $1.60
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CRIS is down 50.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When CRIS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CRIS is currently trading at $0.45, which is considered slightly low relative to its 30-day fair value range of $0.42 to $0.78.

Technical Outlook: Technically, CRIS is in a strong downtrend. Immediate support is located at $0.43, while resistance sits at $1.60. Short-term momentum is weak, with the stock down 22.2% recently.

Market Sentiment: CRIS scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $42.67 (+9488.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $0.42 - $0.78
Company Quality Score 41/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 47.4%

Trading Range & Key Levels

30-Day Trading Range $0.42 - $0.78
Current vs Trading Range SLIGHTLY LOW
Support Level $0.43
Resistance Level $1.60
Current Trend Strong Downtrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (36/100)
  • BEARISH: Downward momentum (-22.2%)
  • BULLISH: Trading 9488.0% below Wall St target ($42.67)
  • WARNING: Composite score 41/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.07
Wall Street Target $42.67 (+9488.0%)
Revenue Growth (YoY) -66.0%
Share CRIS Analysis

Share this live CRIS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CRIS)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary: Curis reported a loss of $8.1 million in Q3, resulting in a per-share loss of $1.94.
Key Retail Themes: earnings report
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CRIS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceutical…
BUY
28 analysts
$978 41 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
22 analysts
$296 37 SELL
NAMS
NewAmsterdam Pharma Comp…
STRONG BUY
16 analysts
$50 55 HOLD
PRAX
Praxis Precision Medicin…
STRONG BUY
21 analysts
$650 30 SELL
DYN
Dyne TherapeuticsΒ Inc
STRONG BUY
17 analysts
$34 52 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CRIS Research Pages
CRIS Technical Chart CRIS Price Prediction CRIS Intrinsic Value DCF CRIS Earnings Date CRIS Investment Advisor CRIS Fair Price Analyzer CRIS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals